Advanced search
Publication Cover
Breast Cancer Management Volume 12, 2023 - Issue 2
Journal homepage
942
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Patients with HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Real-World Study in Italy

Valentina Perrone1 CliCon S.R.L. Società Benefit, Health Economics & Outcomes Research, Bologna, 40141, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5018-490X
ORCID Icon,
Melania Dovizio1 CliCon S.R.L. Società Benefit, Health Economics & Outcomes Research, Bologna, 40141, ItalyORCID Iconhttps://orcid.org/0000-0003-0301-7767
ORCID Icon,
Melania Leogrande1 CliCon S.R.L. Società Benefit, Health Economics & Outcomes Research, Bologna, 40141, Italy
,
Antonella Tamma2 Eli Lilly Italy S.P.A., Sesto Fiorentino, 50019, Italy
,
Massimo Giovannitti3 Eli Lilly Italy S.P.A., Roma, 00144, Italy
,
Carlotta Buzzoni2 Eli Lilly Italy S.P.A., Sesto Fiorentino, 50019, Italy
&
Luca Degli Esposti1 CliCon S.R.L. Società Benefit, Health Economics & Outcomes Research, Bologna, 40141, ItalyORCID Iconhttps://orcid.org/0000-0002-7020-6659
ORCID Icon show all
Article: BMT68 | Received 24 Jul 2023, Accepted 20 Nov 2023, Published online: 20 Dec 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.